Commonwealth Consolidated ActsIn respect of each application for an extension approved by the Commissioner under section 76 in a financial year, the patent holder must lodge with the Secretary of the Department, before the end of the following financial year, a return setting out the following information:
(a) details of the amount and origin of any Commonwealth funds spent in the research and development of the drug which was the subject of the application; and
(b) the name of any body:
(i) with which the applicant has a contractual agreement; and
(ii) which is in receipt of Commonwealth funds; and
(c) the total amount spent on each type of research and development, including pre-clinical research and clinical trials, in respect of the drug which was the subject of the application.
AustLII: Copyright Policy
| Disclaimers
| Privacy Policy
| Feedback